Soleno Therapeutics, Inc. · NASDAQ:SLNO

Sinclair Andrew disposed of 10,491 Soleno Therapeutics, Inc. shares (Form 4)

Traded May 18, 2026 · Filed May 18, 2026

On May 18, 2026, Sinclair Andrew (Director) disposed of 10,491 Soleno Therapeutics, Inc. shares, leaving 0 shares. Filed May 18, 2026 (Form 4).

Disposed of
10,491 shares
Holding after
0 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockDisposition10,4910Direct

Source

View original at SEC

Related